EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes

Beáta Szebeni, Apor Veres-Székely iD, Domonkos Pap iD, Péter Bokrossy, Zoltán Varga iD, Anikó Gaál, Judith Mihály, Éva Pállinger iD, István M Takács, Csenge Pajtók iD, Mária Bernáth, György S Reusz und 2 weitere

Cells · 2024

DOI: 10.3390/cells13070605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Beáta Szebeni und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Center, MTA Center of Excellence, Semmelweis University, 1083 Budapest, Hungary. Hauptthemen laut MEDLINE: Peritoneal Fibrosis, Peritoneal Dialysis, Extracellular Vesicles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Semmelweis University, Hungarian Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among patients on peritoneal dialysis (PD), 50–80% will develop peritoneal fibrosis, and 0.5–4.4% will develop life-threatening encapsulating peritoneal sclerosis (EPS). Here, we investigated the role of extracellular vesicles (EVs) on the TGF-β- and PDGF-B-driven processes of peritoneal fibrosis. EVs were isolated from the peritoneal dialysis effluent (PDE) of children receiving continuous ambulatory PD. The impact of PDE-EVs on the epithelial–mesenchymal transition (EMT) and collagen production of the peritoneal mesothelial cells and fibroblasts were investigated in vitro and in vivo in the chlorhexidine digluconate (CG)-induced mice model of peritoneal fibrosis. PDE-EVs showed spherical morphology in the 100 nm size range, and their spectral features, CD63, and annexin positivity were characteristic of EVs. PDE-EVs penetrated into the peritoneal mesothelial cells and fibroblasts and reduced their PDE- or PDGF-B-induced proliferation. Furthermore, PDE-EVs inhibited the PDE- or TGF-β-induced EMT and collagen production of the investigated cell types. PDE-EVs contributed to the mesothelial layer integrity and decreased the submesothelial thickening of CG-treated mice. We demonstrated that PDE-EVs significantly inhibit the PDGF-B- or TGF-β-induced fibrotic processes in vitro and in vivo, suggesting that EVs may contribute to new therapeutic strategies to treat peritoneal fibrosis and other fibroproliferative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal FibrosisPeritoneal DialysisExtracellular VesiclesChildHumansMiceAnimalsTransforming Growth Factor betaPeritoneumCollagen

Stichwörter der Autor:innen

extracellular vesiclesfibrosismesenchymal transitionperitoneal dialysistherapy

Substanzen

Transforming Growth Factor betaCollagen

Autor:innen und Institutionen

  • Pediatric Center, MTA Center of Excellence, Semmelweis University, 1083 Budapest, Hungary.
  • HUN-REN-SU Pediatrics and Nephrology Research Group, 1052 Budapest, Hungary.
  • TTK Biological Nanochemistry Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, 1117 Budapest, Hungary.
  • Department of Genetics, Cell- and Immunobiology, Semmelweis University, 1089 Budapest, Hungary.

ORCID-Profile: Apor Veres-Székely, Domonkos Pap, Zoltán Varga, Éva Pállinger, Csenge Pajtók

Förderung

  • National Research, Development and Innovation Office
  • Semmelweis University
  • Hungarian Research Network
  • New National Excellence Program of the Ministry for Culture and Innovation from the Source of the National Research, Development and Innovation Fund
  • the New National Excellence Program of the Ministry for Culture and Innovation from the Source of the National Research, Development and Innovation Fund
  • Hungarian Academic of Sciences, János Bolyai Research Scholarship.
  • Hungarian Academy of Sciences, János Bolyai Research Scholarship

Zitieren

APA

Szebeni, B., Veres-Székely, A., Pap, D., Bokrossy, P., Varga, Z., Gaál, A., Mihály, J., Pállinger, É., Takács, I. M., Pajtók, C., Bernáth, M., Reusz, G. S., Szabó, A. J., & Vannay, Á. (2024). Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes. Cells. https://doi.org/10.3390/cells13070605

Vancouver

Szebeni B, Veres-Székely A, Pap D, Bokrossy P, Varga Z, Gaál A, et al. Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes. Cells. 2024. doi:10.3390/cells13070605

BibTeX
@article{Szebeni2024,
  author = {Szebeni, Beáta and Veres-Székely, Apor and Pap, Domonkos and Bokrossy, Péter and Varga, Zoltán and Gaál, Anikó and Mihály, Judith and Pállinger, Éva and Takács, István M and Pajtók, Csenge and Bernáth, Mária and Reusz, György S and Szabó, Attila J and Vannay, Ádám},
  title = {Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13070605}
}
Kostenlos starten →